C4 Therapeutics, Inc.·4

Jul 2, 4:17 PM ET

Anderson Kenneth Carl 4

4 · C4 Therapeutics, Inc. · Filed Jul 2, 2025

Insider Transaction Report

Form 4
Period: 2025-07-01
Transactions
  • Award

    Common Stock

    2025-07-01$1.51/sh+7,616$11,500135,225 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    47,316
  • Common Stock

    (indirect: By Trust)
    16,939
  • Common Stock

    (indirect: By Trust)
    16,939
  • Common Stock

    (indirect: By Trust)
    61,265
  • Common Stock

    (indirect: By Trust)
    61,265
Footnotes (6)
  • [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025.
  • [F3]Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F4]Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F5]Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F6]Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    wk-form4_1751487429.xmlPrimary

    FORM 4